NEW YORK, Jan. 15, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nu Skin Enterprises, Inc. ("Nu Skin" or the "Company") (NYSE: NUS). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 237.
The investigation concerns whether Nu Skin and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On Wednesday, January 15, 2014, shares of Nu Skin fell sharply following a report from the Chinese newspaper People's Daily, alleging that Nu Skin's Chinese operations amount to a pyramid scheme and are in violation of the laws of the People's Republic of China ("PRC").
On this news, shares of Nu Skin fell $25.84 per share to more than 18.05%, on intraday trading to a price of $110.63 on January 15, 2014.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE The Pomerantz Firm